Fused bicyclic oxazolidinone CETP inhibitor

Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.

Saved in:
Bibliographic Details
Main Authors LIU JIAN, VACHAL PETR, SHA DEYOU, SHAO PENGCHENG PATRICK, SUN WANYING, KATIPALLY REVATHI REDDY, YE FENG
Format Patent
LanguageEnglish
Published 24.05.2016
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.
Bibliography:Application Number: US201414480202